4//SEC Filing
Sofinnova Management X, L.L.C. 4
Accession 0001104659-22-091184
CIK 0001868734other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 3:46 PM ET
Size
8.8 KB
Accession
0001104659-22-091184
Insider Transaction Report
Form 4
Sofinnova Venture Partners X, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2022-08-11$30.00/sh+500,000$15,000,000→ 6,073,949 total(indirect: By Sofinnova Venture Partners X, L.P.)
Sofinnova Management X, L.L.C.
10% Owner
Transactions
- Purchase
Common Stock
2022-08-11$30.00/sh+500,000$15,000,000→ 6,073,949 total(indirect: By Sofinnova Venture Partners X, L.P.)
Katabi Maha
10% Owner
Transactions
- Purchase
Common Stock
2022-08-11$30.00/sh+500,000$15,000,000→ 6,073,949 total(indirect: By Sofinnova Venture Partners X, L.P.)
Footnotes (1)
- [F1]The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X. Dr. James I. Healy and Dr. Maha Katabi are managing members of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. Each of SM X and Dr. Katabi disclaims beneficial ownership of such shares except to the extent of its or her respective pecuniary interest therein. Dr. Healy is a director of the Issuer and files separate Section 16 reports.
Documents
Issuer
CinCor Pharma, Inc.
CIK 0001868734
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001680194
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 3:46 PM ET
- Size
- 8.8 KB